4.8 Article

Stage of change and motivation to healthier lifestyle in non-alcoholic fatty liver disease

期刊

JOURNAL OF HEPATOLOGY
卷 58, 期 4, 页码 771-777

出版社

ELSEVIER
DOI: 10.1016/j.jhep.2012.11.031

关键词

Lifestyle; Psychological factors; Physical activity; Healthy diet

资金

  1. European Community [HEALTH-F2-2009-241762]

向作者/读者索取更多资源

Backgrounds 82 Aims: Healthy diet and physical activity are the treatment cornerstones of non-alcoholic fatty liver disease (NAFLD); their effectiveness is however limited by difficulties in implementing lifestyle changes. We aimed at determining the stage of change and associated psychological factors as a prerequisite to refine strategies to implement behavior changes. Methods: We studied 138 consecutive NAFLD patients (73% male, age 19-73 years). The diagnosis was confirmed by liver biopsy in 64 cases (steatohepatitis, 47%). All cases completed the validated EMME-3 questionnaire, consisting of two parallel sets of instruments (for diet and physical activity, respectively) and providing stages of change according to transtheoretical model. Logistic regression analysis was used to identify factors associated with stages making behavioral changes more demanding. Results: The individual profiles were variable; for diet, no cases had precontemplation as prevalent stage of change (highest score in individual profiles); 36% had contemplation. For physical activity, 50% were classified in either precontemplation or contemplation. Minor differences were recorded in relation to associated metabolic complications or steatohepatitis. Logistic regression identified male sex (odds ratio, 4.51; 95% confidence interval, 1.69-12.08) and age (1.70; 1.20-2.43 per decade) as the independent parameters predicting precontemplation or contemplation for diet. No predictors were identified for physical activity. Conclusions: NAFLD cases have scarce readiness to lifestyle changes, particularly with regard to physical activity. Defining stages of change and motivation offers the opportunity to improve clinical care of NAFLD people through individual programs exploiting the powerful potential of behavioral counseling, an issue to be tested in longitudinal studies. (C) 2012 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Psychology, Clinical

The impact of the COVID-19 pandemic on intensive cognitive behavioral therapy outcomes in patients with anorexia nervosa-A cohort study

Riccardo Dalle Grave, Anna Dalle Grave, Elena Bani, Alessandra Oliosi, Maddalena Conti, Laura Dametti, Simona Calugi

Summary: The study assessed the impact of COVID-19 on the efficacy of an intensive treatment for anorexia nervosa, finding that patients treated during the pandemic showed improvement in psychopathology, but to a lesser extent compared to those treated before the pandemic.

INTERNATIONAL JOURNAL OF EATING DISORDERS (2023)

Editorial Material Gastroenterology & Hepatology

The treatment of diabetes in advanced liver disease: Change of a paradigm

Maria Letizia Petroni, Lucia Brodosi, Giulio Marchesini

ANNALS OF HEPATOLOGY (2023)

Article Cardiac & Cardiovascular Systems

Improved glycaemic control in patients with type 2 diabetes has a beneficial impact on NAFLD, independent of change in BMI or glucose lowering agent

Santo Colosimo, Garry D. Tan, Maria Letizia Petroni, Giulio Marchesini, Jeremy W. Tomlinson

Summary: The current treatment for NAFLD focuses on lifestyle intervention to achieve significant weight loss and reduce cardiovascular risk. In patients with T2D, glucose lowering agents that promote weight loss have shown a beneficial impact on NAFLD. However, it is unclear whether glucose lowering can improve NAFLD in T2D patients independent of weight loss.

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2023)

Article Nutrition & Dietetics

Lifestyle Intervention in NAFLD: Long-Term Diabetes Incidence in Subjects Treated by Web- and Group-Based Programs

Maria Letizia Petroni, Lucia Brodosi, Angelo Armandi, Francesca Marchignoli, Elisabetta Bugianesi, Giulio Marchesini

Summary: A study compared a web-based intervention (WBI) with a standard group-based intervention (GBI) for the prevention and treatment of non-alcoholic fatty liver disease (NAFLD), and found that both interventions had similar effects on weight loss and the risk of developing diabetes in NAFLD patients. The study followed 546 NAFLD individuals for 60 months and observed similar changes in weight and incidence of diabetes between the two intervention groups.

NUTRIENTS (2023)

Editorial Material Gastroenterology & Hepatology

Editorial: should NAFLD be included in the definition of Metabolic Syndrome?

Santo Colosimo, Giulio Marchesini

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)

Editorial Material Endocrinology & Metabolism

Hunting for Progressive NAFLD in Type 2 Diabetes: Do Not Trust Liver Enzymes!

Egeria Scoditti, Giulio Marchesini, Amalia Gastaldelli

DIABETES CARE (2023)

Article Medicine, Research & Experimental

Efficacy and tolerability of a specific blend of amino acids in patients with anorexia nervosa treated in a hospital setting: study protocol for a randomized controlled trial

Riccardo Dalle Grave, Simona Calugi, Chiara Ruocco, Mirko Chimini, Agnese Segala, Maurizio Ragni, Michele Carruba, Alessandra Valerio, Enzo Nisoli

Summary: This study aims to evaluate the efficacy of supplementing a mixture of essential amino acids (EAA) and tricarboxylic acid (TCA) cycle intermediates in increasing lean body mass (LBM) and improving physical and psychological outcomes in patients with anorexia nervosa (AN) who undergo specialized intensive treatment for eating disorders. The results of this study will provide insights on the effectiveness of supplementation with EAA and TCA intermediates in improving LBM and other important physical and psychological outcomes in AN patients who regain weight with specialized intensive treatment.

TRIALS (2023)

Review Biochemistry & Molecular Biology

An Overview of Hepatocellular Carcinoma Surveillance Focusing on Non-Cirrhotic NAFLD Patients: A Challenge for Physicians

Annalisa Cespiati, Felice Cinque, Marica Meroni, Rosa Lombardi, Paola Dongiovanni, Anna Ludovica Fracanzani

Summary: Non-alcoholic fatty liver disease (NAFLD) is a common cause of liver disease worldwide, with potential progression to hepatocellular carcinoma (HCC). The prevalence of NAFLD and consequently HCC is expected to increase in the coming years, posing a significant public health problem. Monitoring HCC in NAFLD patients has limitations, and new biomarkers and scores have been proposed for early diagnosis. This review explores the differences in HCC features between NAFLD and non-NAFLD patients, as well as the limitations of tumor surveillance in NAFLD patients and new biomarkers for early diagnosis.

BIOMEDICINES (2023)

Article Psychology, Clinical

The Irrational Food Beliefs Scale: Validation of the Italian Version in Patients with Obesity

Laura Dametti, Elena Bani, Chiara Tomasi, Anna Dalle Grave, Rossella Derrigo, Mirko Chimini, Riccardo Dalle Grave, Simona Calugi

Summary: This study aimed to propose the Italian version of the Irrational Food Beliefs Scale (IFBS) and examine its psychometric properties. The results demonstrated that the Italian version of the IFBS has good psychometric properties in Italian patients with obesity and validated its use.

JOURNAL OF RATIONAL-EMOTIVE AND COGNITIVE-BEHAVIOR THERAPY (2023)

Article Gastroenterology & Hepatology

Long-term follow-up of web-based and group-based behavioural intervention in NAFLD in a real world clinical setting

Maria Letizia Petroni, Santo Colosimo, Lucia Brodosi, Angelo Armandi, Flavio Bertini, Danilo Montesi, Elisabetta Bugianesi, Giulio Marchesini

Summary: Web-based behavioural intervention is feasible and effective in non-alcoholic fatty liver disease (NAFLD), expanding the cohort involved in behavioural programs and reducing the risk of progressive disease.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)

Article Endocrinology & Metabolism

Impact of migration on diabetes burden: audit in the metropolitan area of Bologna, Italy

G. Marchesini, D. Gibertoni, C. Giansante, V. Perlangeli, R. Grilli, L. Scudeller, C. Descovich, P. Pandolfi

Summary: This study investigated the impact of diabetes in immigrants on the Italian healthcare system and their compliance with standard protocols. The findings showed that the prevalence of diabetes was slightly higher in immigrants compared to the general population, and immigrants had poorer metabolic control and adherence to diagnostic and therapeutic protocols.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2023)

Article Psychology, Clinical

Effectiveness of enhanced cognitive behaviour therapy for patients aged 14 to 25: A promising treatment for anorexia nervosa in transition-age youth

Riccardo Dalle Grave, Massimiliano Sartirana, Anna Dalle Grave, Simona Calugi

Summary: The effectiveness of enhanced cognitive behaviour therapy (CBT-E) was evaluated on patients with anorexia nervosa (AN) aged 14 to 25. The study found that patients who participated in CBT-E treatment showed significant weight gain and reduced scores for clinical impairment and eating-disorder psychopathology at the end of treatment and at 20-week follow-up.

EUROPEAN EATING DISORDERS REVIEW (2023)

Article Endocrinology & Metabolism

Insulin resistance and metabolic flexibility as drivers of liver and cardiac disease in T2DM

Santo Colosimo, Sandip Kumar Mitra, Tirthankar Chaudhury, Giulio Marchesini

Summary: This review investigates the mechanisms through which metabolic flexibility and insulin resistance contribute to the progression of NAFLD and heart disease. Both play a critical role in glucose and lipid metabolism, and disruption of metabolic flexibility leads to abnormal lipid metabolism and fat accumulation in the liver, while insulin resistance affects cardiac glucose metabolism and lipid metabolism, leading to impaired cardiac function. Regular physical activity promotes metabolic flexibility, while weight loss achieved through calorie restriction improves insulin sensitivity.

DIABETES RESEARCH AND CLINICAL PRACTICE (2023)

Article Psychiatry

Risk of binge eating disorder in patients with metabolic dysfunction-associated steatotic liver disease

Lucia Brodosi, Michele Stecchi, Francesca Marchignoli, Elisabetta Lucia, Lucia Magnani, Valeria Guarneri, Maria Letizia Petroni, Giulio Marchesini, Loris Pironi

Summary: This study aimed to evaluate the association between metabolic dysfunction-associated steatotic liver disease (MASLD) and eating disorders. The results showed that binge eating disorder (BED) was present in approximately 17.8% of MASLD patients screened in a specialized metabolic disorders unit. This study highlights the importance of addressing eating disorders in the treatment of MASLD.

EATING AND WEIGHT DISORDERS-STUDIES ON ANOREXIA BULIMIA AND OBESITY (2023)

Article Psychiatry

McArdle disease in a patient with anorexia nervosa: a case report

Riccardo Dalle Grave, Enrico Patacca, Maddalena Conti, Fabio Soave, Laura Dametti, Anna Dalle Grave, Simona Calugi

Summary: McArdle disease and anorexia nervosa have a detrimental bidirectional interaction. Furthermore, laboratory parameter alterations commonly attributed to eating disorders may delay the diagnosis of metabolic muscle diseases. On the other hand, the coexistence of a chronic disease like McArdle disease can help engage patients in actively addressing their eating disorder by adopting a healthy lifestyle.

EATING AND WEIGHT DISORDERS-STUDIES ON ANOREXIA BULIMIA AND OBESITY (2022)

暂无数据